Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.310
-0.100 (-4.15%)
At close: Mar 13, 2026, 4:00 PM EDT
2.350
+0.040 (1.73%)
After-hours: Mar 13, 2026, 4:17 PM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $820.3 million as of March 13, 2026. Its market cap has decreased by -45.92% in one year.
Market Cap
820.30M
Enterprise Value
1.11B
1-Year Change
-45.92%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $820.30M, an increase of 123.94%. That is a compound annual growth rate of 5.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 846.95M | -25.50% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 1.28B |
| Harrow | 1.27B |
| Collegium Pharmaceutical | 1.10B |
| Alvotech | 1.09B |
| Pacira BioSciences | 1.00B |
| Cronos Group | 948.99M |
| Amphastar Pharmaceuticals | 824.83M |
| Tilray Brands | 802.73M |